NEW YORK (Reuters Health) – The high risk of fractures in the first year after solid organ transplantation can be roughly halved with bisphosphonate or vitamin D treatment,…
NEW YORK (Reuters Health) – Delivery of the antispasmodic, antimuscarinic agent oxybutynin in a topical gel relieves urinary symptoms and improves health-related quality of life in women with…
NEW YORK (Reuters Health) – Despite having a favorable effect on cytokine levels, perioperative methylprednisolone does not reduce the incidence of lung injury after pulmonary thromboendarterectomy (PTE), according…
NEW YORK (Reuters Health) – In patients with acute coronary syndrome undergoing percutaneous coronary intervention (PCI) prasugrel shows the most favorable benefit-to-risk ratio in the core group of…
NEW YORK (Reuters Health) – In low-risk women, exercise treadmill testing (ETT) gives similar results to exercise myocardial perfusion imaging (MPI) and is less expensive, researchers report in…
NEW YORK (Reuters Health) – Implantation of cardiac implantable electrophysiological devices (CIED) is associated with increasing rates of complications and mortality, according to results of 3 studies published…
NEW YORK (Reuters Health) – Patients with chronic internal carotid artery occlusion who successfully undergo carotid artery stenting show improvement in global cognitive function, Taiwanese researchers report in…
NEW YORK (Reuters Health) – Asymptomatic carotid artery stenosis does not increase the risk of stroke or mortality after coronary artery bypass graft (CABG) surgery, according to a…
NEW YORK (Reuters Health) – The combination of epirubicin and ifosfamide is effective in patients with relapsed or refractory small cell lung cancer (SCLC), researchers from France report…
NEW YORK (Reuters Health) – A closed-loop hydration and fluid balancing system protects against contrast-induced acute kidney injury in high-risk patients, according to results of a study published…
